Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study

Breast cancer is the second leading cause of death for women in the United States, and early detection could offer patients the opportunity to receive early intervention. The current methods of diagnosis rely on mammograms and have relatively high rates of false positivity, causing anxiety in patients. We sought to identify protein markers in saliva and serum for early detection of breast cancer. A rigorous analysis was performed for individual saliva and serum samples from women without breast disease, and women diagnosed with benign or malignant breast disease, using isobaric tags for relative and absolute quantitation (iTRAQ) technique, and employing a random effects model. A total of 591 and 371 proteins were identified in saliva and serum samples from the same individuals, respectively. The differentially expressed proteins were mainly involved in exocytosis, secretion, immune response, neutrophil-mediated immunity and cytokine-mediated signaling pathway. Using a network biology approach, significantly expressed proteins in both biological fluids were evaluated for protein–protein interaction networks and further analyzed for these being potential biomarkers in breast cancer diagnosis and prognosis. Our systems approach illustrates a feasible platform for investigating the responsive proteomic profile in benign and malignant breast disease using saliva and serum from the same women.

[1]  R. Sinha,et al.  A Pan-Cancer Atlas of Differentially Interacting Hallmarks of Cancer Proteins , 2022, Journal of personalized medicine.

[2]  Costel C. Darie,et al.  Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer , 2022, Proteomes.

[3]  F. Penault-Llorca,et al.  Circulating proteins as predictive and prognostic biomarkers in breast cancer , 2022, Clinical proteomics.

[4]  Ingmar Schoen,et al.  Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration , 2022, Journal of thrombosis and haemostasis : JTH.

[5]  R. Sinha,et al.  Evaluating electronic cigarette cytotoxicity and inflammatory responses in vitro , 2022, Tobacco induced diseases.

[6]  S. Manifar,et al.  Salivary biomarkers in breast cancer diagnosis: A systematic review and diagnostic meta‐analysis , 2022, Cancer medicine.

[7]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[8]  J. O’Sullivan,et al.  Von Willebrand factor and cancer; metastasis and coagulopathies , 2020, Journal of thrombosis and haemostasis : JTH.

[9]  R. Sinha,et al.  Pan-cancer mapping of differential protein-protein interactions , 2020, Scientific Reports.

[10]  B. Takkouche,et al.  Salivary biomarkers for cancer diagnosis: a meta-analysis , 2020, Annals of medicine.

[11]  Georgios I. Karaolanis,et al.  gamma-H2AX: A potential biomarker in breast cancer , 2019, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  Huiyu Wang,et al.  Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer , 2019, Biomarker Research.

[13]  Kara Dolinski,et al.  The BioGRID interaction database: 2019 update , 2018, Nucleic Acids Res..

[14]  A. Angelucci,et al.  Non-conventional role of haemoglobin beta in breast malignancy , 2017, British Journal of Cancer.

[15]  Weidong Wei,et al.  Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis , 2017, Journal of Molecular Medicine.

[16]  H. Si,et al.  Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study , 2016, PloS one.

[17]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[18]  M. H. Ornellas,et al.  Proteomic profile of saliva and plasma from women with impalpable breast lesions. , 2016, Oncology letters.

[19]  C. Hollenbeak,et al.  "Omics" of Selenium Biology: A Prospective Study of Plasma Proteome Network Before and After Selenized-Yeast Supplementation in Healthy Men. , 2016, Omics : a journal of integrative biology.

[20]  Costel C. Darie,et al.  Salivary proteomics and biomarkers in neurology and psychiatry , 2015, Proteomics. Clinical applications.

[21]  A. Martínez-Torteya,et al.  SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis , 2013, PloS one.

[22]  A. Alayash,et al.  Molecular controls of the oxygenation and redox reactions of hemoglobin. , 2013, Antioxidants & redox signaling.

[23]  T. Sur iTRAQ, a New Prospect of Toxicogenomics , 2013 .

[24]  M. Dwek,et al.  A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer. , 2013, Cancer letters.

[25]  Ralf Herwig,et al.  The ConsensusPathDB interaction database: 2013 update , 2012, Nucleic Acids Res..

[26]  Diederick E Grobbee,et al.  Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study , 2011, BMC Cancer.

[27]  C. Hollenbeak,et al.  Functional proteomic analysis reveals sex-dependent differences in structural and energy-producing myocardial proteins in rat model of alcoholic cardiomyopathy. , 2011, Physiological genomics.

[28]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[29]  David Elashoff,et al.  Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer , 2010, PloS one.

[30]  Sanford Weisberg,et al.  An R Companion to Applied Regression , 2010 .

[31]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[32]  W. Dubinsky,et al.  A Comparison of the Proteomic Expression in Pooled Saliva Specimens from Individuals Diagnosed with Ductal Carcinoma of the Breast with and without Lymph Node Involvement , 2009, Journal of oncology.

[33]  R. Nagler Saliva as a tool for oral cancer diagnosis and prognosis. , 2009, Oral oncology.

[34]  W. Bonner,et al.  γ-H2AX in Cancer Cells: A Potential Biomarker for Cancer Diagnostics, Prediction and Recurrence , 2006, Cell cycle.

[35]  Arya M. Sharma,et al.  Retinol-Binding Protein 4 in Human Obesity , 2006, Diabetes.

[36]  Michaela Zwick,et al.  The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[37]  Guanghui Wang,et al.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of Proteome Research.

[38]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[39]  C. Streckfus,et al.  Saliva as a diagnostic fluid. , 2002, Oral diseases.

[40]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[41]  D B Kopans,et al.  Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.

[42]  J. Elmore,et al.  Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.

[43]  S. Rubin,et al.  Efficacy of screening mammography. A meta-analysis. , 1995, JAMA.

[44]  In‐San Kim,et al.  Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer , 2016, Oncotarget.

[45]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[46]  Yong-wei Hu,et al.  Clinicopathological significance of reduced SPARCL1 expression in human breast cancer. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[47]  Stanley Lemeshow,et al.  Applied Logistic Regression, Second Edition , 1989 .

[48]  K. Kerlikowske,et al.  Outcomes of modern screening mammography. , 1997, Journal of the National Cancer Institute. Monographs.